Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Asahi Kasei Pharma Denmark A/S
A/S
Active
Advertising protection
CVR 40948074
Gdanskgade 18, 2150
Nordhavn
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 2019 · 6 years old
— employees
Monitor
Share
Denmark
/
Companies
/
Manufacture of pharmaceutical preparations
/
Asahi Kasei Pharma Denmark A/S
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
-1M
-2M
-3M
-4M
2021: -3M
-3M
2021
2022: -1M (+67% vs 2021)
-1M
+67%
2022
2023: -1M (0% vs 2022)
-1M
0%
2023
2024: -1M (0% vs 2023)
-1M
0%
2024
2025: -1M (0% vs 2024)
-1M
0%
2025
EBITDA
DKK millions
0M
-1M
-2M
-3M
-4M
2021: -3M
-3M
2021
2022: -1M (+67% vs 2021)
-1M
+67%
2022
2023: -1M (0% vs 2022)
-1M
0%
2023
2024: -1M (0% vs 2023)
-1M
0%
2024
2025: -1M (0% vs 2024)
-1M
0%
2025
Income statement
DKK thousands
Item
2025
2024
2023
2022
2021
Gross profit
-639
-758
-941
-1.217
-3.438
Staff expenses
-0
-0
-0
-0
-0
EBITDA
-639
-758
-941
-1.217
-3.438
Depreciation & amort.
-0
-0
-0
-0
-0
EBIT
-639
-758
-941
-1.217
-3.438
Net financials
34.090
33.677
24.568
7.493
-621.557
Profit before tax
33.451
32.919
23.627
6.276
-624.995
Tax
7.379
7.426
5.395
1.606
498
Net profit
26.073
25.493
18.233
4.670
-625.493
Balance sheet
DKK thousands
Item
2025
2024
2023
2022
2021
Total assets
982.981
957.054
930.142
912.639
8.389.485
Equity
977.458
951.386
925.893
907.660
8.386.903
Long-term debt
0
0
0
0
0
Short-term debt
5.523
5.669
4.249
4.979
2.582
Total debt
5.523
5.669
4.249
4.979
2.582
Financial ratios
5-year trend
EBITDA margin (of gross profit)
<−999 %
This company
2021
2025
Equity ratio
99,4 %
This company
38,2 %
Market median
This company
Market median
160% above market
2021
2025
Return on equity
2,7 %
This company
18,4 %
Market median
This company
Market median
85% below market
2021
2025
Net profit margin (of gross profit)
>999 %
This company
2021
2025
Asset turnover (of gross profit)
-0,00×
This company
2021
2025
Debt / equity
0,01×
This company
0,62×
Market median
This company
Market median
98% below market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2024-04-01 – 2025-03-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2023-04-01 – 2024-03-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2022-04-01 – 2023-03-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2021-04-01 – 2022-03-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2019-11-21 – 2021-03-31
View
PDF
More on Asahi Kasei Pharma Denmark A/S
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
